Link Pharma Chem has informed that Suresh Balram Dhatrak (DIN: 00365256) and Devang Uttamchand Shah (DIN: 00704950), Independent directors have completed their tenure of 10 years, second term on 26th September, 2024 and consequently ceased to be an Independent Directors of the Company with effective from close of business hours on 26th September, 2024. The Board of Directors and the Management of the Company placed on record their deep appreciation for the contributions made by Suresh Balram Dhatrak and Devang Uttamchand Shah during their association with the Company over the years. Disclosure required pursuant to Regulation 30 of the Listing Regulations read with Para A of Part A of Schedule III to the Listing Regulations read with the SEBI Circular No. SEBI/HO/CFD/CFDPoD1/P/CIR/2023/123 dated July 13, 2023, with regard to change in Directors and Key Managerial Personnel is given as per enclosure. The circular resolution for noting of completion of tenure of above directors was passed by board of directors on 05th October, 2024 and immediately on the same day, we have intimated about the same to the stock exchange.
The above information is a part of company’s filings submitted to BSE.